BeOne Medicines Ltd.
- Last sale
- Nov 12, 2026 · -0.96%
- Market cap
- $617.76B
- 1.48B shares
- Filings
- 1,057
Q3 2026+40.2% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+73.1% FY25 yoy
- $617.76B
- 674.7×
- 93.5×
- 106.1×
- 0.23%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,343,033,000 | reported | |
| FY 2024 | 2024-12-31 | $3,810,241,000 | reported | |
| FY 2023 | 2023-12-31 | $2,458,779,000 | reported | |
| FY 2022 | 2022-12-31 | $1,415,921,000 | reported | |
| FY 2021 | 2021-12-31 | $1,176,283,000 | reported | |
| FY 2020 | 2020-12-31 | $308,874,000 | reported | |
| FY 2019 | 2019-12-31 | $428,212,000 | reported | |
| FY 2018 | 2018-12-31 | $198,220,000 | reported | |
| FY 2017 | 2017-12-31 | $238,387,000 | reported | |
| FY 2016 | 2016-12-31 | $1,070,000 | reported | |
| FY 2015 | 2015-12-31 | $8,816,000 | reported | |
| FY 2014 | 2014-12-31 | $13,035,000 | reported |
Segments
LineFY2025ShareChange
United States$2.88B54%+47.1%
PRC$1.68B31%+19.0%
Europe- total revenue$611.37M11%+68.6%
Other$171.81M3.2%+118.0%
Other———
Total$5.34B
Pharmaceutical preparations
BeOne Medicines Ltd. is the 17th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
OGNOrganon & Co.$6.2B2.9%3.0%$3.7B
ONCBeOne Medicines Ltd. (this company)$5.3B40.2%5.4%$617.8B
ELANElanco Animal Health Inc$4.7B6.2%4.9%$13.3BJAZZJazz Pharmaceuticals plc$4.3B4.9%8.3%$15.4BPRGOPerrigo Co PLC$4.3B2.8%33.5%$2.2BGMABGenmab A/S$3.7B19.2%25.9%—ALNYAlnylam Pharmaceuticals, Inc.$3.7B65.2%8.4%$21.0BBMRNBioMarin Pharmaceutical Inc$3.2B12.9%10.8%$11.0BUTHRUnited Therapeutics Corp$3.2B10.6%41.9%$25.3BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
BeOne Medicines Ltd. · CIK 1651308 · Engraved from SEC EDGAR